Zealand Pharma AS (ZLDPF)
115.06
-1.00
(-0.86%)
USD |
OTCM |
Nov 14, 09:32
Zealand Pharma Shareholders Equity (Quarterly): 1.331B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.331B |
June 30, 2024 | 1.349B |
March 31, 2024 | 410.53M |
December 31, 2023 | 236.49M |
September 30, 2023 | 257.31M |
June 30, 2023 | 252.08M |
March 31, 2023 | 98.55M |
December 31, 2022 | 117.43M |
September 30, 2022 | 48.43M |
June 30, 2022 | 70.89M |
March 31, 2022 | 106.50M |
December 31, 2021 | 141.24M |
September 30, 2021 | 184.99M |
June 30, 2021 | 221.92M |
March 31, 2021 | 262.08M |
December 31, 2020 | 203.19M |
September 30, 2020 | 250.70M |
June 30, 2020 | 271.53M |
March 31, 2020 | 179.50M |
December 31, 2019 | 178.96M |
September 30, 2019 | 206.50M |
June 30, 2019 | 147.28M |
March 31, 2019 | 162.95M |
December 31, 2018 | 171.00M |
September 30, 2018 | 193.05M |
Date | Value |
---|---|
June 30, 2018 | 49.05M |
March 31, 2018 | 72.26M |
December 31, 2017 | 82.94M |
September 30, 2017 | 101.14M |
June 30, 2017 | 27.92M |
March 31, 2017 | 36.30M |
December 31, 2016 | 39.56M |
September 30, 2016 | 32.75M |
June 30, 2016 | 16.08M |
March 31, 2016 | 27.16M |
December 31, 2015 | 36.95M |
September 30, 2015 | 24.05M |
June 30, 2015 | 24.51M |
March 31, 2015 | 30.32M |
December 31, 2014 | 41.28M |
September 30, 2014 | 53.90M |
June 30, 2014 | 54.77M |
March 31, 2014 | 63.52M |
December 31, 2013 | 58.51M |
September 30, 2013 | 65.48M |
June 30, 2013 | 69.20M |
March 31, 2013 | 76.06M |
December 31, 2012 | 87.03M |
September 30, 2012 | 92.92M |
June 30, 2012 | 89.84M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
48.43M
Minimum
Sep 2022
1.349B
Maximum
Jun 2024
308.59M
Average
212.55M
Median
Shareholders Equity (Quarterly) Benchmarks
Novo Nordisk AS | 18.05B |
Genmab AS | 4.781B |
Ascendis Pharma AS | -344.22M |
Galecto Inc | 20.94M |
Evaxion Biotech AS | 0.074M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.442B |
Total Liabilities (Quarterly) | 111.84M |
Debt to Equity Ratio | 0.0316 |
Current Ratio | 35.49 |
Net Debt Paydown Yield | -0.10% |